Moleculin Expands Phase 3 MIRACLE Clinical Trial into the Country of Georgia, Enrollment Update and Future Plans
Provided By GlobeNewswire
Last update: Jul 9, 2025
Secured approval from the Regulation Agency for Medical and Pharmaceutical Activities (RAMPA) in Georgia for Phase 2B/3 MIRACLE trial
Recent EU approval from the European Medicines Agency (EMA) boosts trial profile
Read more at globenewswire.com
